Attention-deficit hyperactivity disorder epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(33 intermediate revisions by 5 users not shown)
Line 1: Line 1:
{{CMG}} {{AE}} {{CP}}
__NOTOC__
{{CMG}}; {{AE}} {{KS}}, {{HW}}


{{ADHD}}
{{ADHD}}


==Overview==
==Overview==
A review of 102 studies estimated ADHD's worldwide [[prevalence]] in people under the age of 19 to be 5.29%. 10% of males, and 4% of females have been diagnosed in the U.S.<ref> {{PDFlink|[http://www.cdc.gov/nchs/data/series/sr_10/sr10_221.pdf "National Health Interview survey, 2002"]|3.71&nbsp;[[Mebibyte|MiB]]<!-- application/pdf, 3892622 bytes -->}}. Centers for Disease Control (March, 2004). Retrieved on [[December 11]], [[2006]].</ref>
The prevalence of attention-deficit hyperactivity disorder (ADHD) is estimated to be 5,000 per 100,000 (5%) children and 2,500 per 100,000 (2.5%) adults.<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> Boys are more commonly affected by ADHD than girls. The male to female ratio is 2 to 1.<ref name="#10">Briars, L., & Todd, T. (2016). A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder. The Journal of Pediatric Pharmacology and Therapeutics : JPPT, 21(3), 192–206. http://doi.org/10.5863/1551-6776-21.3.192.</ref>


==Prevalance==
==Epidemiology and Demographics==
A review of 102 studies estimated ADHD's worldwide [[prevalence]] in people under the age of 19 to be 5.29%. There was wide variability in prevalence estimates, mostly due to the methodological characteristics of studies (for example, diagnostic criteria used) and, to a lesser extent, geographic location (North America having a significantly higher rate of ADHD than Africa and the Middle East).<ref name="Polanczyk">{{cite journal|author=Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA|title=The worldwide prevalence of ADHD: a systematic review and metaregression analysis|journal=Am J Psychiatry|date=2007|volume=164|issue=6|pages=942–48 |pmid=17541055|doi=10.1176/appi.ajp.164.6.942}}</ref>  
===Prevalence===
*The [[prevalence]] of ADHD in children is 5,000 per 100,000 (5%) of the overall population.<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>


==Gender==
*The prevalence of ADHD in adults is 2,500 per 100,000 (2.5%) of the overall population.<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> The prevalence of diagnosis is increasing in adults to 354 per 1000,000 in 2011<ref name="pmid29765219">{{cite journal| author=Polyzoi M, Ahnemark E, Medin E, Ginsberg Y| title=Estimated prevalence and incidence of diagnosed ADHD and health care utilization in adults in Sweden - a longitudinal population-based register study. | journal=Neuropsychiatr Dis Treat | year= 2018 | volume= 14 | issue=  | pages= 1149-1161 | pmid=29765219 | doi=10.2147/NDT.S155838 | pmc=5944447 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29765219  }} </ref>.
10% of males, and (only) 4% of females have been diagnosed in the U.S.<ref> {{PDFlink|[http://www.cdc.gov/nchs/data/series/sr_10/sr10_221.pdf "National Health Interview survey, 2002"]|3.71&nbsp;[[Mebibyte|MiB]]<!-- application/pdf, 3892622 bytes -->}}.  Centers for Disease Control (March, 2004). Retrieved on [[December 11]], [[2006]].</ref> This apparent sex difference may reflect either a difference in susceptibility or that females with ADHD are less likely to be diagnosed than males.<ref>Staller J, Faraone SV. (2006) "Attention-deficit hyperactivity disorder in girls: epidemiology and management." ''CNS Drugs''. 2006;20(2):107–23. PMID 16478287</ref><ref>Biederman J, Faraone SV. (2004) "The [[Massachusetts General Hospital]] studies of gender influences on attention-deficit/hyperactivity disorder in youth and relatives." ''Psychiatr Clin North Am''. Jun;27(2):225–32. PMID 15063995</ref>
 
===Incidence===
*The percentage of children age 4-17 years diagnosed with ADHD increased from 7.8 percent in 2003 to 11 percent in 2011.<ref name="pmid22420039">{{cite journal| author=Zuvekas SH, Vitiello B| title=Stimulant medication use in children: a 12-year perspective. | journal=Am J Psychiatry | year= 2012 | volume= 169 | issue= 2 | pages= 160-6 | pmid=22420039 | doi=10.1176/appi.ajp.2011.11030387 | pmc=3548321 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22420039  }} </ref><ref name= "CDC Statistics"> Center for Disease Control and Prevention http://www.cdc.gov/ncbddd/adhd/data.html Accessed on Oct 14, 2016. </ref>
 
===Age===
*ADHD is usually first diagnosed in school-aged children. For an adult to be diagnosed with ADHD, the patient’s symptoms must have been present prior to the age of 12.<ref name="#1">National Institute of Mental Health (NIH). (2016). "Attention Deficit Hyperactivity Disorder."</ref> However, the average age at diagnosis is 7 years.<ref name= "CDC Statistics"> Center for Disease Control and Prevention http://www.cdc.gov/ncbddd/adhd/data.html Accessed on Oct 14, 2016. </ref>
 
===Gender===
*ADHD is more prevalent in males than in females. The male to female ratio is approximately 2 to 1.<ref name="#10">Briars, L., & Todd, T. (2016). A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder. The Journal of Pediatric Pharmacology and Therapeutics : JPPT, 21(3), 192–206. http://doi.org/10.5863/1551-6776-21.3.192.</ref>
 
===Race===
*ADHD is observed in patients of all racial/ethnic backgrounds, but does appear to be most common in non-Hispanic Caucasians.<ref name="#10">Briars, L., & Todd, T. (2016). A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder. The Journal of Pediatric Pharmacology and Therapeutics : JPPT, 21(3), 192–206. http://doi.org/10.5863/1551-6776-21.3.192.</ref>


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WH}}
{{WS}}
[[Category:Psychiatry]]
[[Category:Pediatrics]]

Latest revision as of 02:27, 9 November 2023

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2], Haleigh Williams, B.S.

Attention-deficit hyperactivity disorder Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Attention-Deficit Hyperactivity Disorder from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Psychiatric Examination

Laboratory Findings

Imaging Findings

Treatment

Medical Therapy

Psychotherapy

Brain Stimulation Therapy

Cost-Effectiveness of Therapy

Monitoring Response to Therapy

Future or Investigational Therapies

Case Studies

Case #1

Template:Attention-deficit hyperactivity disorder On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Attention-deficit hyperactivity disorder epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Attention-deficit hyperactivity disorder epidemiology and demographics

CDC on Attention-deficit hyperactivity disorder epidemiology and demographics

Attention-deficit hyperactivity disorder epidemiology and demographics in the news

Blogs on Attention-deficit hyperactivity disorder epidemiology and demographics

Directions to Hospitals Treating Attention-deficit hyperactivity disorder

Risk calculators and risk factors for Attention-deficit hyperactivity disorder epidemiology and demographics

Overview

The prevalence of attention-deficit hyperactivity disorder (ADHD) is estimated to be 5,000 per 100,000 (5%) children and 2,500 per 100,000 (2.5%) adults.[1] Boys are more commonly affected by ADHD than girls. The male to female ratio is 2 to 1.[2]

Epidemiology and Demographics

Prevalence

  • The prevalence of ADHD in children is 5,000 per 100,000 (5%) of the overall population.[1]
  • The prevalence of ADHD in adults is 2,500 per 100,000 (2.5%) of the overall population.[1] The prevalence of diagnosis is increasing in adults to 354 per 1000,000 in 2011[3].

Incidence

  • The percentage of children age 4-17 years diagnosed with ADHD increased from 7.8 percent in 2003 to 11 percent in 2011.[4][5]

Age

  • ADHD is usually first diagnosed in school-aged children. For an adult to be diagnosed with ADHD, the patient’s symptoms must have been present prior to the age of 12.[6] However, the average age at diagnosis is 7 years.[5]

Gender

  • ADHD is more prevalent in males than in females. The male to female ratio is approximately 2 to 1.[2]

Race

  • ADHD is observed in patients of all racial/ethnic backgrounds, but does appear to be most common in non-Hispanic Caucasians.[2]

References

  1. ↑ 1.0 1.1 1.2 Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.
  2. ↑ 2.0 2.1 2.2 Briars, L., & Todd, T. (2016). A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder. The Journal of Pediatric Pharmacology and Therapeutics : JPPT, 21(3), 192–206. http://doi.org/10.5863/1551-6776-21.3.192.
  3. ↑ Polyzoi M, Ahnemark E, Medin E, Ginsberg Y (2018). "Estimated prevalence and incidence of diagnosed ADHD and health care utilization in adults in Sweden - a longitudinal population-based register study". Neuropsychiatr Dis Treat. 14: 1149–1161. doi:10.2147/NDT.S155838. PMC 5944447. PMID 29765219.
  4. ↑ Zuvekas SH, Vitiello B (2012). "Stimulant medication use in children: a 12-year perspective". Am J Psychiatry. 169 (2): 160–6. doi:10.1176/appi.ajp.2011.11030387. PMC 3548321. PMID 22420039.
  5. ↑ 5.0 5.1 Center for Disease Control and Prevention http://www.cdc.gov/ncbddd/adhd/data.html Accessed on Oct 14, 2016.
  6. ↑ National Institute of Mental Health (NIH). (2016). "Attention Deficit Hyperactivity Disorder."

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Attention-deficit_hyperactivity_disorder_epidemiology_and_demographics&oldid=1736296"